Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products ...

CVS and Walgreens quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation into possible cancer risks.

The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary recalls of the drug and an investigation by the Food and Drug ...

People who are taking over-the-counter ranitidine should consider taking one of several other heartburn drugs that are available.

Although several studies did find that taking ranitidine could increase the concentration of nitrites in the stomach—and at least one found a statistically significant increase in nitrosamines ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

The same day that Valisure announced a “Citizen Petition” with the FDA urging a recall of ranitidine, numerous lawsuits were filed against drug manufacturers.

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...